Barbara Łasut-Szyszka

Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity

Małgorzata Krześniak, Artur Zajkowicz, Agnieszka Gdowicz‐Kłosok et al. · Cellular Signalling · 2020 · 39 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein

Artur Zajkowicz, Agnieszka Gdowicz‐Kłosok, Małgorzata Krześniak et al. · Neuroscience Letters · 2018 · 31 citations

Life Sciences, Molecular Biology, Molecular Genetics +14

Methylglyoxal (MGO) inhibits proliferation and induces cell death of human glioblastoma multiforme T98G and U87MG cells

Monika Paul-Samojedny, Barbara Łasut-Szyszka, Adam Pudełko et al. · Biomedicine & Pharmacotherapy · 2016 · 19 citations

Medicine, Oncology, Pharmacology +9

Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity

Barbara Łasut-Szyszka, Beata Małachowska, Agnieszka Gdowicz‐Kłosok et al. · International Journal of Molecular Sciences · 2021 · 15 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes

Barbara Łasut-Szyszka, Agnieszka Gdowicz‐Kłosok, Beata Małachowska et al. · Chemico-Biological Interactions · 2024 · 13 citations

Life Sciences, Molecular Biology, Oncology +17